Evidence map›Paper›PMID 39659571›Full record

ArticleTheranostics2024

[

Limeng He, Yan Yang, Xu Cao, Xianjun Zhu, Nan Liu, Xiaoyuan Chen, Jingjing Zhang, Wei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. AVS-referenced diagnostic performance ofFrontiers in endocrinology · 2026
    Pooled it
  3. Pooled it
  4. Primary aldosteronism.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Review
  7. Synthesis, preclinical evaluation and clinical application of a novel heterodimeric tracerEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  8. Article
  9. Real world experience with [Frontiers in endocrinology · 2026
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Limeng HeDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Yan YangDepartment of Endocrinology & Metabolism, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xu CaoDepartment of Endocrinology & Metabolism, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xianjun ZhuDepartment of Endocrinology & Metabolism, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Nan LiuDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xiaoyuan ChenDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
Jingjing ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
Wei ZhangDepartment of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HyperaldosteronismPositron Emission Tomography Computed TomographyReceptors, CXCR4Adrenal Gland NeoplasmsAdultAgedFemaleFluorine RadioisotopesHeterocyclic Compounds, 1-RingHumansMaleMiddle AgedRadiopharmaceuticals1,4,7-triazacyclononane-N,N',N''-triacetic acidCXCR4 protein, humanFluorine RadioisotopesHeterocyclic Compounds, 1-RingRadiopharmaceuticalsReceptors, CXCR4[18F]AlF-NOTA-pentixather[18F]AlF-NOTA-T140Aldosterone-producing adenomachemokine receptorPET/CTPrimary aldosteronism

Identifiers

PMID39659571
PMCPMC11626951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.